AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29471478
Drug: Internet-delivered Cognitive-Behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered Cognitive-Behavioral Therapy for Insomnia (iCBT-I)
Trial: 12610815
Drug: BAY 12‐9566
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 12‐9566 (100 mg)
Trial: 22363673
Drug: AZT monotherapy
RxNorm normalized name: AZT
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AZT monotherapy
Trial: 8709213
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (AZT + ddI or AZT + ddC)
Trial: 7036960
Drug: Antacid (hourly)
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid (hourly)
Trial: 18042521
Drug: Dietary plant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary plant sterols (2 g/day)
Trial: 27816052
Drug: n-6 (ω6)
RxNorm normalized name: 18:3 (n-6)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-6 (ω6) meal (7.4 g; grapeseed oil)
Trial: 27816052
Drug: Saturated fat
RxNorm normalized name: Saturated fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saturated fat meal (16 g; coconut oil)
Trial: 19943881
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg day(-1)
Trial: 19943881
Drug: Enoxaparin 1
RxNorm normalized name: ENOXAPARIN 100MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 1 mg kg(-1) twice daily
Trial: 12642046
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg on the first day, followed by 250 mg daily for 4 days)
Trial: 1951212
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin (IVIG) 750 mg/kg administered within 72 hours of admission and every 14 days until discharge or age 3 months.
Trial: 1951212
Drug: Placebo (albumin)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (albumin) administered within 72 hours of admission and every 14 days until discharge or age 3 months.
Trial: 8033435
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin (IVIG)
Trial: 20195589
Drug: Salbutamol via
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol via pressurized metered-dose inhaler with spacer (50 microg/kg)
Trial: 18640172
Drug: Conventional cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cigarette (CC)
Trial: 1900011
Drug: rt-PA with
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA with intravenous metoprolol 15 mg acutely and then 200 mg orally daily
Trial: 6141051
Drug: Felodipine (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (6.25 mg to 25 mg)
Trial: 30191722
Drug: Internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered cognitive behavioural therapy for insomnia (Sleep Healthy Using The Internet)
Trial: 25652579
Drug: Internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered cognitive behavioural therapy for insomnia
Trial: 30236079
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment plus I3C and EGCG plus long-term platinum-taxane chemotherapy (arm 3)
Trial: 30236079
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment alone without neoadjuvant platinum-taxane chemotherapy (control arm 4)
Trial: 30236079
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment alone (control arm 5)
Trial: 1587073
Drug: Augmented therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented therapy
Trial: 10206320
Drug: Azimilide 100
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 100 mg day(-1)
Trial: 10206320
Drug: Azimilide 150
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 150 mg day(-1)
Trial: 10206320
Drug: Azimilide 200
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 200 mg day(-1)
Trial: 10206320
Drug: Azimilide 100
RxNorm normalized name: Azimilide
DrugBank: Azimilide (DB04957)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azimilide 100 mg day(-1) with 3-day loading for >55 years
Trial: 30430
Drug: Methylphenidate, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate, 0.5 mg/kg intravenously
Trial: 31081694
Drug: Tirasemtiv (tolerated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirasemtiv (tolerated dose)
Trial: 26944609
Drug: Cortisol administration
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol administration
Trial: 20008240
Drug: Maintenance or
RxNorm normalized name: Cystex Urinary Health Maintenance oral soluti
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance or consolidation therapies
Trial: 20008240
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with novel agents
Trial: 17442550
Drug: NSAIDs (aspirin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (aspirin, ibuprofen)
Trial: 23937999
Drug: Paracetamol (acetaminophen)
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol (acetaminophen)
Trial: 11772663
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) steroid plus oral placebo
Trial: 11772663
Drug: Oral steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroid plus IM placebo
Trial: 9833199
Drug: Outpatient therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient therapy, drop-in center, and brokered case management
Trial: 2286465
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg)
Trial: 10884878
Drug: Cefotaxime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (1 g)
Trial: 2504593
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ofloxacin and cefotaxime
Trial: 341901
Drug: fluocortin butylester
RxNorm normalized name: fluocortin
DrugBank: Fluocortin (DB13223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluocortin butylester (Vaspit) in cream, ointment, and fatty ointment
Trial: 28407129
Drug: Citrate-containing dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrate-containing dialysate plus a heparin-grafted membrane (CiTED)
Trial: 25997827
Drug: 150 mL
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mL ropivacaine (2 mg/mL) and 0.5 mL epinephrine (1 mg/mL)
Trial: 25997827
Drug: 150 mL
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mL 0.9% saline (control)
Trial: 23652169
Drug: Intraoperative colloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative colloid administration
Trial: 23652169
Drug: No intraoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intraoperative colloid administration
Trial: 17111006
Drug: CHO +
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO + EAA + Glutamine (0.3 g/kg BW)
Trial: 8773436
Drug: Aminophylline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (5 mg/kg over 20 min)
Trial: 28743247
Drug: Paclitaxel monotherapy
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel monotherapy (80 mg/m2 weekly, 3 weeks on, 1 week off)
Trial: 28743247
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus sorafenib (400 mg orally, twice a day, starting dose of 200 mg)
Trial: 22298569
Drug: WR(+) -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WR(+) - wheat/rye bread with in situ‐produced AXOS (180 g/d)
Trial: 22298569
Drug: W(‐) -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W(‐) - refined wheat flour bread without AXOS (180 g/d)
Trial: 20570218
Drug: Brachytherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brachytherapy with (125)I seed implants, prescription dose of 145 Gy.
Trial: 20570218
Drug: Brachytherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brachytherapy with (125)I seed implants in non-small prostate volume patients, 120 patients in total.
Trial: 26925905
Drug: Liposic ointment
RxNorm normalized name: Lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposic ointment
Trial: 21223250
Drug: Reduced chemotherapy
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced chemotherapy (standard risk; SR)
Trial: 21223250
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (medium risk; MR)
Trial: 19895208
Drug: Standard short-course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard short-course anti-TB treatment (2EHRZ3/4RH3)
Trial: 16052108
Drug: Dexmedetomidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1 microg/kg over 15 min followed by 0.2 microg x kg x h infusion)
Trial: 16052108
Drug: Fentanyl (0.1-0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.1-0.2 mg intravenous on demand)
Trial: 9845131
Drug: 5-Fluorouracil (5FU)
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-Fluorouracil (5FU) and cisplatin (CDDP) chemotherapy
Trial: 30348127
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no chemotherapy)
Trial: 8082346
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg bolus injection of alteplase over 15 min (maximum dose 50 mg)
Trial: 30520111
Drug: 308-nm excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm excimer laser monotherapy
Trial: 19793378
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg/day (alpha‐blocker group)
Trial: 19793378
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tamsulosin 0.2 mg/day and dutasteride 0.5 mg/day
Trial: 17693178
Drug: Aspirin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (75 mg per day)
Trial: 9797360
Drug: Ciprofloxacin (500-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500-750 mg twice a day)
Trial: 8106700
Drug: Metoprolol (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (titrated to a mean maximal dose of 87 mg/day)
Trial: 2764852
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg, t.i.d.)
Trial: 21726916
Drug: glimepiride-metformin
RxNorm normalized name: Glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: glimepiride-metformin
Trial: 17126774
Drug: Propofol (Diprifusor)
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol (Diprifusor) target-controlled infusion at a predetermined target concentration starting at 2.5 mug/mL; step size of 0.1 microg/mL
Trial: 17126774
Drug: Propofol (Diprifusor)
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol (Diprifusor) target-controlled infusion
Trial: 14559317
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil omega-3 fatty acids (4.5 g/d) + sulfasalazine (2 g/d)
Trial: 14559317
Drug: Sulfasalazine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (2 g/d) alone
Trial: 16918888
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg/day)
Trial: 6374866
Drug: Oxmetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine 400 mg twice daily
Trial: 482183
Drug: Cimetidine 1
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1 g daily
Trial: 23314489
Drug: 12 daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 daily local mud packs and generalized thermal baths with sulfate‐calcium‐magnesium‐fluorides mineral water added to usual treatment
Trial: 23314489
Drug: Regular outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular outpatient care routine (exercise, NSAIDs and/or analgesics)
Trial: 23314489
Drug: 12 daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 daily local mud packs and generalized thermal baths
Trial: 22170369
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g WG/d for 16 wk
Trial: 22170369
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g WG/d for 8 wk followed by 120 g WG/d for 8 wk
Trial: 15786932
Drug: PADMA 28,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PADMA 28, 3 x 2 capsules daily for 4 weeks
Trial: 8543487
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg bd
Trial: 8543487
Drug: Imipenem/cilastatin 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin 500 mg bd
Trial: 8543487
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg tds
Trial: 8543487
Drug: Ceftazidime 500
RxNorm normalized name: ceftazidime 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 500 mg tds
Trial: 8288503
Drug: Ceftazidime 1
RxNorm normalized name: ceftazidime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 1 g tds
Trial: 1962599
Drug: Droloxifene 20
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene 20 mg once daily
Trial: 1962599
Drug: Droloxifene 40
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene 40 mg once daily
Trial: 7046782
Drug: Ordinary terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary terbutaline 5 mg three times daily
Trial: 19680279
Drug: Other treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatment options (control group)
Trial: 18004683
Drug: 0.3 g.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g.kg(‐1) BW NaHCO3 ingestion with passive recovery (BICARB P)
Trial: 18004683
Drug: 0.3 g.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g.kg(‐1) BW NaHCO3 ingestion with active recovery (BICARB A)
Trial: 16421365
Drug: Inhaled hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled hypertonic saline (5 ml of 7 percent sodium chloride) four times daily without amiloride pretreatment
Trial: 16421365
Drug: Inhaled hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled hypertonic saline with amiloride pretreatment
Trial: 8873228
Drug: Nabumetone (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone (1000 mg once daily)
Trial: 15556830
Drug: Rofecoxib (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (12.5 mg)
Trial: 3877303
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg/kg bolus injection over 5 seconds
Trial: 3877303
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg/kg bolus injection
Trial: 3877303
Drug: Propofol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.5 mg/kg and 2.0 mg/kg
Trial: 30102965
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of toreforant once daily through week 24
Trial: 24901463
Drug: Announced pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Announced pill count
Trial: 12759558
Drug: Fluoxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine treatment for 8 weeks (control group)
Trial: 10698385
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide 40 ppm
Trial: 2870222
Drug: Verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120 mg three times a day)
Trial: 2870222
Drug: Verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120 mg twice a day)
Trial: 27141627
Drug: Scalp acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scalp acupuncture treatment
Trial: 24140220
Drug: Prophylactic intravenous
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic intravenous antibiotics
Trial: 17490928
Drug: Glipizide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide (10 mg daily for 12 weeks)
Trial: 11833827
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 to 300 mg/d
Trial: 11833827
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 to 20 mg/d
Trial: 8625624
Drug: 10% low‐molecular‐weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% low‐molecular‐weight hydroxyethyl starch solution
Trial: 21892106
Drug: Arm A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A: 40 Gy/20 fractions/4 weeks with concurrent weekly vinorelbine 25 mg/m + cisplatin 20 mg/m
Trial: 21892106
Drug: Arm B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B: 30 Gy/15 fractions/3 weeks with concurrent weekly gemcitabine 200 mg
Trial: 10689005
Drug: Crinone 8%
RxNorm normalized name: Crinone 8% Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8% (90 mg vaginally)
Trial: 10689005
Drug: Prometrium (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prometrium (100 mg orally)
Trial: 27229736
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (n=26): twice weekly 60-min group exercise classes, at least 3 days/week self-directed exercise, daily pedometer, weekly telephone counseling
Trial: 23901023
Drug: EGCG-rich green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: EGCG-rich green tea extract (300-900 mg/day)
Trial: 18303408
Drug: Neoadjuvant platinum/taxanes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant platinum/taxanes chemotherapy
Trial: 9174478
Drug: Reduced calcium
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced calcium intake (280 mg/d)
Trial: 31427252
Drug: Amoxicillin-clavulanate (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanate (45 mg/kg per day)
Trial: 31427252
Drug: Azithromycin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (5 mg/kg per day)
Trial: 25024070
Drug: T-DM1 3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T-DM1 3.6 mg/kg every 3 weeks
Trial: 22967970
Drug: salvia miltiorrhiza
RxNorm normalized name: SALVIA MILTIORRHIZA ROOT
DrugBank: Salvia miltiorrhiza root (DB14337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salvia miltiorrhiza and ligustrazine injection (250 mL glucose injection containing 10 mL concoction, once a day for three days)
Trial: 22967970
Drug: routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: routine treatment methods (fluid resuscitation, anti‐infection treatment, support treatment, organ‐protection treatment)
Trial: 21385192
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg b.d. for 12 months
Trial: 21385192
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg b.d. for 12 months
Trial: 2062329
Drug: 600 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 micrograms of inhaled budesonide twice a day
Trial: 29964041
Drug: Prebiotic supplement
RxNorm normalized name: FlorastorSelect Gut Boost Daily Probiotic and Prebiotic Supplement Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic supplement (2.8 g/d Bimuno containing 1.37 g beta-galactooligosaccharide) plus placebo (Mediterranean-type diet)
Trial: 29964041
Drug: Placebo supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplement (2.8 g xylose) plus low-FODMAP diet